Cargando…
Validation of original and alternative fistula risk scores in postoperative pancreatic fistula
BACKGROUND: In 2013, the fistula risk score (FRS) was developed to assess the risk of clinically relevant postoperative pancreatic fistula (CR‐POPF). In 2017, the alternative FRS (a‐FRS) was proposed. The purpose of this study was to validate the original FRS (o‐FRS) and a‐FRS for CR‐POPF in pancrea...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771591/ https://www.ncbi.nlm.nih.gov/pubmed/31125494 http://dx.doi.org/10.1002/jhbp.638 |
_version_ | 1783455721141043200 |
---|---|
author | Ryu, Youngju Shin, Sang Hyun Park, Dae Joon Kim, Naru Heo, Jin Seok Choi, Dong Wook Han, In Woong |
author_facet | Ryu, Youngju Shin, Sang Hyun Park, Dae Joon Kim, Naru Heo, Jin Seok Choi, Dong Wook Han, In Woong |
author_sort | Ryu, Youngju |
collection | PubMed |
description | BACKGROUND: In 2013, the fistula risk score (FRS) was developed to assess the risk of clinically relevant postoperative pancreatic fistula (CR‐POPF). In 2017, the alternative FRS (a‐FRS) was proposed. The purpose of this study was to validate the original FRS (o‐FRS) and a‐FRS for CR‐POPF in pancreaticoduodenectomy (PD). METHODS: From January 2007 to December 2016, 1,771 patients underwent PD for periampullary cancers. POPF was defined and classified according to the 2016 International Study Group for Pancreatic Fistula. All data were reviewed retrospectively. RESULTS: Pathologic diagnosis other than ductal adenocarcinoma (P < 0.001), pancreas duct diameter (P < 0.001), and body mass index (P < 0.001) were independent risk factors for CR‐POPF. Pancreatic texture (P = 0.534) and estimated blood loss (P = 0.827) were not associated with CR‐POPF. The CR‐POPF incidence increased with increasing o‐FRS score (P < 0.001), and also increased statistically significantly with increasing a‐FRS in the higher risk group (P < 0.001). However, the correlations differed. The area under the curve was 0.629 for o‐FRS and 0.622 for a‐FRS. CONCLUSIONS: Both o‐FRS and a‐FRS might reflect CR‐POPF incidence, but some risk factors had no or low statistical significance. Further research is needed to revise the FRS. |
format | Online Article Text |
id | pubmed-6771591 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67715912019-10-03 Validation of original and alternative fistula risk scores in postoperative pancreatic fistula Ryu, Youngju Shin, Sang Hyun Park, Dae Joon Kim, Naru Heo, Jin Seok Choi, Dong Wook Han, In Woong J Hepatobiliary Pancreat Sci Original Articles BACKGROUND: In 2013, the fistula risk score (FRS) was developed to assess the risk of clinically relevant postoperative pancreatic fistula (CR‐POPF). In 2017, the alternative FRS (a‐FRS) was proposed. The purpose of this study was to validate the original FRS (o‐FRS) and a‐FRS for CR‐POPF in pancreaticoduodenectomy (PD). METHODS: From January 2007 to December 2016, 1,771 patients underwent PD for periampullary cancers. POPF was defined and classified according to the 2016 International Study Group for Pancreatic Fistula. All data were reviewed retrospectively. RESULTS: Pathologic diagnosis other than ductal adenocarcinoma (P < 0.001), pancreas duct diameter (P < 0.001), and body mass index (P < 0.001) were independent risk factors for CR‐POPF. Pancreatic texture (P = 0.534) and estimated blood loss (P = 0.827) were not associated with CR‐POPF. The CR‐POPF incidence increased with increasing o‐FRS score (P < 0.001), and also increased statistically significantly with increasing a‐FRS in the higher risk group (P < 0.001). However, the correlations differed. The area under the curve was 0.629 for o‐FRS and 0.622 for a‐FRS. CONCLUSIONS: Both o‐FRS and a‐FRS might reflect CR‐POPF incidence, but some risk factors had no or low statistical significance. Further research is needed to revise the FRS. John Wiley and Sons Inc. 2019-07-01 2019-08 /pmc/articles/PMC6771591/ /pubmed/31125494 http://dx.doi.org/10.1002/jhbp.638 Text en © 2019 The Authors. Journal of Hepato-Biliary-Pancreatic Sciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Hepato-Biliary-Pancreatic Surgery. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Ryu, Youngju Shin, Sang Hyun Park, Dae Joon Kim, Naru Heo, Jin Seok Choi, Dong Wook Han, In Woong Validation of original and alternative fistula risk scores in postoperative pancreatic fistula |
title | Validation of original and alternative fistula risk scores in postoperative pancreatic fistula |
title_full | Validation of original and alternative fistula risk scores in postoperative pancreatic fistula |
title_fullStr | Validation of original and alternative fistula risk scores in postoperative pancreatic fistula |
title_full_unstemmed | Validation of original and alternative fistula risk scores in postoperative pancreatic fistula |
title_short | Validation of original and alternative fistula risk scores in postoperative pancreatic fistula |
title_sort | validation of original and alternative fistula risk scores in postoperative pancreatic fistula |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771591/ https://www.ncbi.nlm.nih.gov/pubmed/31125494 http://dx.doi.org/10.1002/jhbp.638 |
work_keys_str_mv | AT ryuyoungju validationoforiginalandalternativefistulariskscoresinpostoperativepancreaticfistula AT shinsanghyun validationoforiginalandalternativefistulariskscoresinpostoperativepancreaticfistula AT parkdaejoon validationoforiginalandalternativefistulariskscoresinpostoperativepancreaticfistula AT kimnaru validationoforiginalandalternativefistulariskscoresinpostoperativepancreaticfistula AT heojinseok validationoforiginalandalternativefistulariskscoresinpostoperativepancreaticfistula AT choidongwook validationoforiginalandalternativefistulariskscoresinpostoperativepancreaticfistula AT haninwoong validationoforiginalandalternativefistulariskscoresinpostoperativepancreaticfistula |